ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 259 filers reported holding ISHARES TR in Q3 2013. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $82,438,000 | +23.6% | 737,370 | +6.6% | 0.05% | +8.0% |
| Q4 2018 | $66,686,000 | -25.8% | 691,551 | -6.2% | 0.05% | -15.3% |
| Q3 2018 | $89,892,000 | +51.2% | 737,179 | +36.2% | 0.06% | +43.9% |
| Q2 2018 | $59,460,000 | -25.4% | 541,433 | -27.5% | 0.04% | -29.3% |
| Q1 2018 | $79,659,000 | -34.6% | 746,290 | -34.6% | 0.06% | -33.3% |
| Q4 2017 | $121,750,000 | -42.5% | 1,140,301 | +79.6% | 0.09% | -45.3% |
| Q3 2017 | $211,849,000 | +17.6% | 635,058 | +9.3% | 0.16% | +14.4% |
| Q2 2017 | $180,167,000 | +27.6% | 581,033 | +20.7% | 0.14% | +24.1% |
| Q1 2017 | $141,192,000 | +55.7% | 481,442 | +40.9% | 0.11% | +47.4% |
| Q4 2016 | $90,703,000 | +4.1% | 341,785 | +13.5% | 0.08% | +2.7% |
| Q3 2016 | $87,170,000 | +38989.7% | 301,146 | +34594.2% | 0.07% | – |
| Q2 2014 | $223,000 | -95.3% | 868 | -96.2% | 0.00% | -100.0% |
| Q3 2013 | $4,764,000 | -39.8% | 22,731 | -50.0% | 0.01% | -37.5% |
| Q2 2013 | $7,912,000 | – | 45,504 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |